SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-030984
Filing Date
2004-02-27
Accepted
2004-02-27 12:51:05
Documents
9
Period of Report
2003-12-27

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d10k.htm 10-K 1057640
3 INDEMNIFICATION AGREEMENT WITH HENRIK RASMUSSEN dex1027.htm EX-10.27 31300
4 INDEMNIFICATION AGREEMENT WITH RAAFAT FAHIM dex1028.htm EX-10.28 31310
5 CHANGE IN CONTOL DATED JULY 14, 2003 WITH HENRIK RASMUSSEN dex1029.htm EX-10.29 36846
6 CHANGE IN CONTROL DATED JULY 14, 2003 BETWEEN RAAFAT FAHIM dex1030.htm EX-10.30 36847
7 CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS dex231.htm EX-23.1 2404
8 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex311.htm EX-31.1 6943
9 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex312.htm EX-31.2 7220
10 SECTION 1350 CERTIFICATION dex321.htm EX-32.1 7414
  Complete submission text file 0001193125-04-030984.txt   1220824
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 04633820
SIC: 2836 Biological Products, (No Diagnostic Substances)